Indian Listed Companies to See Shareholder Lock-In Periods Expire this Week
SYNOPSIS: Around 10 listed companies will collectively see more than Rs. 30,000 crore worth of shares become tradable this week as lock-in periods expire, potentially increasing supply without guaranteeing immediate selling. As many as 10 companies are set to see shares worth over Rs. 30,000 crore become eligible for trading this week, as their respective shareholder lock-in periods come to an end. The list includes names such as Lenskart Solutions, Orkla India, Akums Drugs, Dr Agarwals Health Care, along with six other companies. It is important to note that the expiry of a shareholder lock-in does not imply that these shares will be sold in the open market immediately. Instead, the shares simply become eligible for trading, and any actual selling will depend on the decisions of the shareholders. Following are the ten stocks where shareholder lock-in periods are scheduled to expire this week: With a market cap of Rs. 1,677.3 crores, the stock is trading in the red at Rs. 293.5 on BSE, down by over 4 percent on Monday. As many as 16 lakh shares of the company, or 3 percent of its total outstanding shares, will free up in trade on 6th February. At the present market price, these shares are worth around Rs. 47 crore. The stock is trading around 24 percent below its issue price of Rs. 385. M&B Engineering Limited is one of India’s leading Pre-Engineered Buildings (PEBs) players offering comprehensive turnkey solutions, and an integrated manufacturing partner providing ‘design-led-manufacturing’ solutions to the customers, through strategically located manufacturing facilities at Sanand (Gujarat) and Cheyyar (Tamil Nadu) for PEBs and 14 mobile manufacturing units for self-supported roofing systems. With a market cap of Rs. 1,895 crores, the stock was trading in the red at Rs. 481.55 on BSE, down by over 2 percent on Monday. A total of 12 lakh shares, equivalent to 3 percent of its outstanding equity, will be freed for trade on 3rd February. These shares are worth around Rs. 58 crore at the present market price. The stock is trading around 18 percent below its issue price of Rs. 585 per share. Studds Accessories Limited is engaged in the business of manufacturing two-wheeler helmets and motorcycle accessories. With a market cap of Rs. 7,699 crores, the stock was trading in the red at Rs. 562 on BSE, down by around 3 percent on Monday. A total of 34 lakh shares of the company, or 2 percent of its outstanding equity, have been freed for trade today, or 2nd February. At the current market price, these shares are worth around Rs. 191 crore. The stock is trading around 23 percent below its issue price of Rs. 730. Orkla India Limited is an Indian food company engaged in the business of offering a diverse range of food products, from breakfast to lunch and dinner, snacks, beverages, and desserts. It has iconic heritage Indian brands – MTR, Eastern and Rasoi Magic. With a market cap of Rs. 459.4 crores, the stock was trading in the red at Rs. 87.89 on BSE, down by over 3 percent on Monday. A total of 2.51 crores shares, or 48 percent of its outstanding, will be freed in trade on 6th February. At the current market price, these are worth around Rs. 220.6 crores. The stock is trading over 41 percent below its IPO price of Rs. 150 per share. Incorporated in 1996, Laxmi India Finance Limited is engaged in the business of a Non-Banking Financial Company. With a market cap of Rs. 13,751 crores, the stock was trading in the red at Rs. 434.05 on BSE, down by around 2 percent on Monday. As many as 3.64 crore shares of the company, or 12 percent of its outstanding, will be freed for trade on 6th February. At the current market rate, these are worth around Rs. 1,580 crore. The stock is up by around 8 percent from its issue price of Rs. 402 per share. Dr. Agarwal’s Health Care offers a wide range of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. With a market cap of Rs. 6,754 crores, the stock was trading in the red at Rs. 429 on BSE, down by over 3 percent on Monday. As many as 3.15 crore equity shares of the company, or 20 percent of its outstanding equity, will be freed for trade on 3rd February. These shares are worth around Rs. 1,351.4 crore at the present market price. The stock is over 35 percent below its IPO price of Rs. 679 per share. Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) engaged in the business of offering a comprehensive range of pharmaceutical products and services. With a market cap of Rs. 7,111 crores, the stock was trading in the red at Rs. 145.5 on BSE, down by over 3 percent on Monday. A total of 7.93 crore shares of the company, or 16 percent of its total outstanding shares, will see their lock-in period end on 6th February. At the current market price, these are worth around Rs. 1,154 crore. The stock is marginally up by around 3 percent from its issue price of Rs. 150 per share. Sri Lotus Developers and Realty Limited is a developer of residential and commercial properties located in Mumbai, specialising in redevelopment projects within the ultra-luxury and luxury segments of the western suburbs. With a market cap of Rs. 76,464.4 crores, the stock was trading in the green at Rs. 441 on BSE, up by around 1 percent on Monday. A total of 4.07 crore shares of the company, or 2 percent of its outstanding equity, will be freed for trade on 4th February. At the present market price, these shares are valued at Rs. 1,795 crore. The stock is trading up 10 percent from its issue price of Rs. 402 per share. Lenskart Solutions Limited is a technology-focused eyewear company involved in the design, manufacturing, branding, and retail of prescription eyeglasses, sunglasses, contact lenses, and accessories. With a market cap of Rs. 16,688.4 crores, the stock was trading in the green at Rs. 1,420 on BSE, up by over 2 percent on Monday. As many as 7.44 crore equity shares of the company, or 63 percent of its outstanding equity, will be freed for trade on 4th February. At the current market price, those shares are worth around Rs. 10,565 crore. Aditya Infotech Limited (AIL) is engaged in the business of security and surveillance equipment and components under the ‘CP Plus’ brand. In addition, the company offers solutions and services such as fully integrated security systems and Security-as-a-Service directly. With a market cap of Rs. 18,971 crores, the stock was trading in the red at Rs. 948.55 on BSE, down by around 2 percent on Monday. As many as 14.92 crore shares of NSDL, or 75 percent of its outstanding equity, will be freed for trade on 5th February. At the current market price, these shares are worth around Rs. 14,152 crore. The stock is up around 19 percent from its issue price of Rs. 800 per share. National Securities Depository Limited (NSDL) provides an electronic infrastructure for the dematerialisation of securities and facilitates electronic settlement of trades in the Indian Securities Market. Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies ontradebrains.inare their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing. Shivani is a Financial Analyst with 5+ years of experience in finance writing, including 3+ years of hands-on experience in financial analysis. She has extensively covered trending themes across key sectors like green energy, banking, insurance, chemicals, IT, and other emerging industries, while analysing sectoral trends and company fundamentals. Her expertise also includes analysing private equity and venture capital acquisitions, providing comprehensive market overviews, and tracking FII/DII investment movements to gauge overall market direction and investor sentiment.